Nasdaq · CIK 0000731012
HCSG HEALTHCARE SERVICES GROUP INC
Insider trading from SEC Form 4. Last filing 12 d ago. Close $20.59 on Oct 9, 2026, +36% from the 52-week low and -19% from the high.
HEALTHCARE SERVICES GROUP INC (HCSG) has 69 SEC Form 4 filings on file from 15 insiders, the latest filed on Oct 1, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
6 open-market trades have been scored at HCSG. The newest: Andrew M Brophy (SVP & Chief Accounting Officer) sold $54k of stock on Feb 26, 2026, filed Feb 26, 2026, scored 22 (weak), under a 10b5-1 plan. The largest of the 6 shown: John Christopher Shea (EVP & Chief Admin. Officer) sold $1.1M on Feb 18, 2026, scored 60 (notable). 3 insiders sold within 14 days of each other around Feb 26, 2026.
HCSG closed at $20.59 on Oct 9, 2026, 36% above its 52-week low and 19% below its 52-week high.
3 Form 144 notices of planned sales are on file, the latest filed Oct 28, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at HEALTHCARE SERVICES GROUP INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Andrew M Brophy SVP & Chief Accounting Officer sell | $54k 2,490 shares | -14% | +132% from low-2% from high | |
| 74Notable | Patrick J Orr EVP & Chief Revenue Officer sell | $916k 44,615 shares | -100% | +117% from low-9% from high | |
| 60Notable | John Christopher Shea EVP & Chief Admin. Officer sell | $1.1M 54,357 shares | -121% | +117% from low-9% from high | |
| 59Moderate | Patrick J Orr EVP & Chief Revenue Officer sell | $935k 45,500 shares | -50% | +117% from low-9% from high | |
| 39Weak | John Christopher Shea EVP & Chief Admin. Officer sell | $283k 21,368 shares | -39% | +41% from low-15% from high | |
| 0Weak | Andrew M Brophy SVP & Chief Accounting Officer sell | $18k 1,744 shares | -12% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 28, 2025 | ANDREW KUSH Officer | 28,612 0.04% of outstanding | $547k | Oct 28, 2025 | none |
| Oct 27, 2025 | JASON J BUNDICK Officer | 20,996 0.03% of outstanding | $400k | Oct 27, 2025 | none |
| Jul 28, 2025 | John Shea Officer | 21,368 0.03% of outstanding | $283k | Jul 28, 2025 | none |
Transactions
The newest 50 of 256 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Laura K Grant director | AGrant or award Common Stock10b5-1 | +367 | $20.45 | $7,505 | 18,681 | 12 d ago |
| Sep 30, 2026 | Kurt Simmons JR director | AGrant or award Common Stock10b5-1 | +734 | $20.45 | $15k | 31,504 | 12 d ago |
| Sep 30, 2026 | Thomas Gerard Whalen director | AGrant or award Common Stock10b5-1 | +123 | $20.45 | $2,515 | 5,480 | 12 d ago |
| May 27, 2026 | Vikas Singh EVP & Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +2,202 | $20.60 | $45k | 13,212 | May 28, 2026 |
| May 26, 2026 | Jude Visconto director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 14,975 | May 28, 2026 |
| May 26, 2026 | Diane S Casey director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 14,975 | May 28, 2026 |
| May 26, 2026 | Laura K Grant director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 18,008 | May 28, 2026 |
| May 26, 2026 | Dino D Ottaviano director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 15,409 | May 28, 2026 |
| May 26, 2026 | Thomas Michael Gallagher director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 1,969 | May 28, 2026 |
| May 26, 2026 | Thomas Gerard Whalen director | AGrant or award Common Stock10b5-1 | +1,969 | $20.32 | $40k | 5,255 | May 28, 2026 |
| May 26, 2026 | Kurt Simmons JR director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 30,159 | May 28, 2026 |
| May 26, 2026 | Daniela Castagnino director | AGrant or award Common Stock | +1,969 | $20.32 | $40k | 14,975 | May 28, 2026 |
| May 27, 2026 | Vikas Singh EVP & Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -935 | $20.60 | $19k | 12,277 | May 28, 2026 |
| Mar 31, 2026 | Thomas Gerard Whalen director | AGrant or award Common Stock10b5-1 | +135 | $18.55 | $2,504 | 3,286 | Apr 2, 2026 |
| Mar 31, 2026 | Laura K Grant director | AGrant or award Common Stock10b5-1 | +405 | $18.55 | $7,513 | 16,039 | Apr 2, 2026 |
| Mar 31, 2026 | Kurt Simmons JR director | AGrant or award Common Stock10b5-1 | +809 | $18.55 | $15k | 28,190 | Apr 2, 2026 |
| Feb 24, 2026 | Patrick J Orr EVP & Chief Revenue Officer | MOption exercise Common Stock10b5-1 | +3,340 | $0.00 | $0 | 3,340 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew M Brophy SVP & Chief Accounting Officer | FTax withholding Common Stock10b5-1 | -239 | $21.40 | $5,115 | 18,225 | Feb 26, 2026 |
| Feb 24, 2026 | Jason J Bundick EVP/Gen. Counsel/Corp. Secty. | MOption exercise Common Stock10b5-1 | +3,374 | $0.00 | $0 | 31,244 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew Kush EVP & Chief Operating Officer | MOption exercise Common Stock10b5-1 | +4,416 | $0.00 | $0 | 32,948 | Feb 26, 2026 |
| Feb 24, 2026 | Theodore WAHL President & CEO | MOption exercise Common Stock10b5-1 | +22,238 | $0.00 | $0 | 509,101 | Feb 26, 2026 |
| Feb 24, 2026 | John Christopher Shea EVP & Chief Admin. Officer | MOption exercise Common Stock10b5-1 | +4,416 | $0.00 | $0 | 33,708 | Feb 26, 2026 |
| Feb 26, 2026 | Andrew M Brophy SVP & Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -2,490 | $21.75 | $54k | 15,735 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew Kush EVP & Chief Operating Officer | FTax withholding Common Stock10b5-1 | -1,874 | $21.40 | $40k | 31,074 | Feb 26, 2026 |
| Feb 24, 2026 | Jason J Bundick EVP/Gen. Counsel/Corp. Secty. | FTax withholding Common Stock10b5-1 | -1,432 | $21.40 | $31k | 29,812 | Feb 26, 2026 |
| Feb 24, 2026 | Patrick J Orr EVP & Chief Revenue Officer | FTax withholding Common Stock10b5-1 | -1,417 | $21.40 | $30k | 1,923 | Feb 26, 2026 |
| Feb 24, 2026 | Theodore WAHL President & CEO | FTax withholding Common Stock10b5-1 | -9,434 | $21.40 | $202k | 499,667 | Feb 26, 2026 |
| Feb 24, 2026 | John Christopher Shea EVP & Chief Admin. Officer | FTax withholding Common Stock10b5-1 | -1,874 | $21.40 | $40k | 31,834 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew Kush EVP & Chief Operating Officer | MOption exercise Common Stock10b5-1 | +12,618 | $0.00 | $0 | 43,692 | Feb 26, 2026 |
| Feb 24, 2026 | Patrick J Orr EVP & Chief Revenue Officer | MOption exercise Common Stock10b5-1 | +9,543 | $0.00 | $0 | 11,466 | Feb 26, 2026 |
| Feb 24, 2026 | Jason J Bundick EVP/Gen. Counsel/Corp. Secty. | MOption exercise Common Stock10b5-1 | +9,643 | $0.00 | $0 | 39,455 | Feb 26, 2026 |
| Feb 24, 2026 | Theodore WAHL President & CEO | MOption exercise Common Stock10b5-1 | +63,551 | $0.00 | $0 | 563,218 | Feb 26, 2026 |
| Feb 24, 2026 | John Christopher Shea EVP & Chief Admin. Officer | MOption exercise Common Stock10b5-1 | +12,618 | $0.00 | $0 | 44,452 | Feb 26, 2026 |
| Feb 24, 2026 | John Christopher Shea EVP & Chief Admin. Officer | FTax withholding Common Stock10b5-1 | -5,353 | $21.40 | $115k | 39,099 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew Kush EVP & Chief Operating Officer | FTax withholding Common Stock10b5-1 | -5,353 | $21.40 | $115k | 38,339 | Feb 26, 2026 |
| Feb 24, 2026 | Patrick J Orr EVP & Chief Revenue Officer | FTax withholding Common Stock10b5-1 | -4,049 | $21.40 | $87k | 7,417 | Feb 26, 2026 |
| Feb 24, 2026 | Theodore WAHL President & CEO | FTax withholding Common Stock10b5-1 | -26,959 | $21.40 | $577k | 536,259 | Feb 26, 2026 |
| Feb 24, 2026 | Jason J Bundick EVP/Gen. Counsel/Corp. Secty. | FTax withholding Common Stock10b5-1 | -4,091 | $21.40 | $88k | 35,364 | Feb 26, 2026 |
| Feb 24, 2026 | John Christopher Shea EVP & Chief Admin. Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,416 | $0.00 | $0 | 8,830 | Feb 26, 2026 |
| Feb 24, 2026 | Andrew Kush EVP & Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,416 | $0.00 | $0 | 8,830 | Feb 26, 2026 |
| Feb 24, 2026 | Patrick J Orr EVP & Chief Revenue Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,340 | $0.00 | $0 | 6,678 | Feb 26, 2026 |
| Feb 24, 2026 | Jason J Bundick EVP/Gen. Counsel/Corp. Secty. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,374 | $0.00 | $0 | 6,748 | Feb 26, 2026 |
| Feb 24, 2026 | Theodore WAHL President & CEO | MOption exercise Restricted Stock Unitsderivative10b5-1 | -22,238 | $0.00 | $0 | 44,476 | Feb 26, 2026 |
| Feb 18, 2026 | Patrick J Orr EVP & Chief Revenue Officer | SOpen-market sale Common Stock | -11,167 | $20.55 | $229k | 33,448 | Feb 20, 2026 |
| Feb 18, 2026 | Patrick J Orr EVP & Chief Revenue Officer | SOpen-market sale Common Stock | -33,448 | $20.52 | $686k | 0 | Feb 20, 2026 |
| Feb 18, 2026 | John Christopher Shea EVP & Chief Admin. Officer | SOpen-market sale Common Stock | -15,500 | $20.52 | $318k | 29,292 | Feb 19, 2026 |
| Feb 17, 2026 | Theodore WAHL President & CEO | AGrant or award Common Stock | +8,511 | $20.93 | $178k | 495,374 | Feb 19, 2026 |
| Feb 18, 2026 | Patrick J Orr EVP & Chief Revenue Officer | MOption exercise Common Stock | +21,075 | $18.10 | $381k | 65,690 | Feb 19, 2026 |
| Feb 18, 2026 | John Christopher Shea EVP & Chief Admin. Officer | MOption exercise Common Stock | +29,579 | $18.10 | $535k | 58,871 | Feb 19, 2026 |
| Feb 18, 2026 | Patrick J Orr EVP & Chief Revenue Officer | MOption exercise Common Stock | +7,016 | $13.72 | $96k | 72,706 | Feb 19, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Andrew M BrophySVP & Chief Accounting Officer
- Jason J BundickEVP/Gen. Counsel/Corp. Secty.
- Diane S Caseydirector
- Daniela Castagninodirector
- Thomas Michael Gallagherdirector
- Laura K Grantdirector
- Andrew KushEVP & Chief Operating Officer
- Patrick J OrrEVP & Chief Revenue Officer
- Dino D Ottavianodirector
- John Christopher SheaEVP & Chief Admin. Officer
- Kurt Simmons JRdirector
- Vikas SinghEVP & Chief Financial Officer
- Jude Viscontodirector
- Theodore WAHLPresident & CEO
- Thomas Gerard Whalendirector
Questions about HCSG
Answered from the filings on this page, as of the latest one.
Are insiders buying HCSG?
No. In the last 90 days no insider at HEALTHCARE SERVICES GROUP INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade HCSG on the open market?
Andrew M Brophy (SVP & Chief Accounting Officer) sold $54k of HCSG on Feb 26, 2026 and filed the Form 4 on Feb 26, 2026. InsiderTell scored 22 (weak), under a 10b5-1 plan, with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at HEALTHCARE SERVICES GROUP INC?
15 people have filed a Form 4 at HEALTHCARE SERVICES GROUP INC, among them Andrew M Brophy (SVP & Chief Accounting Officer), Jason J Bundick (EVP/Gen. Counsel/Corp. Secty.), Diane S Casey (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.